Please try another search
Kontafarma China Holdings Limited, an investment holding company, engages in the manufacture and sale of prescription drugs in Mainland China, Singapore, Taiwan, and internationally. It operates in Pharmaceutical Business and Fitness Business segments. The company offers chemical drugs and prescribed traditional Chinese medicines; operates fitness and yoga centers; operates in the franchise business; and provides consultation services for fitness and health activities. It also researches and develops medical products; and offers corporate advisory services. The company was formerly known as Tongfang Kontafarma Holdings Limited and changed its name to Kontafarma China Holdings Limited in September 2022. The company was founded in 1993 and is headquartered in Wan Chai, Hong Kong. Kontafarma China Holdings Limited is a subsidiary of China Health Management Investment Limited.
Name | Age | Since | Title |
---|---|---|---|
Pingyan Bai | 51 | 2021 | Executive Chairman |
Chaowen Jiang | 57 | 2017 | VP, CEO & Executive Director |
Ruibin Zhang | 54 | 2014 | Independent Non-Executive Director |
Sze Chung Chan | 54 | 2011 | Independent Non-Executive Director |
Junxi Zhang | 61 | 2015 | Independent Non-Executive Director |
Yu Huang | 54 | 2014 | Non-Executive Director |
Hongjie Chai | 51 | 2020 | Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review